XM does not provide services to residents of the United States of America.
C
C

CrestNicholson

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

UK homebuilders gain as cooling labour market boosts rate cut hopes

BUZZ-UK homebuilders gain as cooling labour market boosts rate cut hopes ** Shares of UK housebuilders .FTNMX402020 rise 1.3% after Britain's labour market showed more signs of cooling in April as the unemployment rate rose ** Official data showed the jobless rate for the three months to April rose to 4.4% from 4.3% between January and March, the h
B
B
B
C
H
P
R
T
U

4Imprint, AstraZeneca, Bellway

EUROPE RESEARCH ROUNDUP-4Imprint, AstraZeneca, Bellway June 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including 4Imprint, AstraZeneca and Bellway, on Wednesday. HIGHLIGHTS * 4Imprint FOUR.L : HSBC raises target price to 6370p from 6060p * AstraZeneca AZN.L : HSBC raises target price to 14070p from 12950p * Bellway Plc BWY.L : Berenberg raises target price to 2900p from 2500p * Berkeley Group BKGH.L : Berenberg raises target price to
A
A
B
B
B
B
B
C
E
G
G
H
H
I
M
M
O
P
R
R
S
B
E
M
N
P
R
S
T

UK homebuilders down as inflation falls less than expected

BUZZ-UK homebuilders down as inflation falls less than expected ** Shares of UK housebuilders .FTNMX402020 decline 1.2% after inflation in Britain fell less than expected in April and a key core measure barely dropped, prompting investors to pull bets on a rate cut next month ** Consumer prices rose by an annual 2.3% last month, down sharply from a
B
B
B
C
P
R
T
U

UK property, housing stocks gain as US inflation data boost rate cut hopes

BUZZ-UK property, housing stocks gain as US inflation data boost rate cut hopes ** The FTSE Real Estate index .FTUB3510 , which includes commercial property firms and real estate investment trusts (REITs), gains 2.5% ** UK homebuilders' index .FTNMX402020 rises 2.5% ** Shares of UK real estate firms gain after US consumer prices increased less than expected in April, suggesting that inflation resumed its downward trend at the start of the second quarter in a boost to financial market expectation
B
B
B
C
D
H
P
R
R
S
S
B
L
T
U

Carlsberg, Danske Bank, Teleperformance

EUROPE RESEARCH ROUNDUP- Carlsberg, Danske Bank, Teleperformance May 10 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Carlsberg, Danske Bank and Teleperformance, on Friday. HIGHLIGHTS * Carlsberg A/S CARLB.CO : HSBC raises target price to DKK 1040 from DKK 1030 * Danske Bank DANSKE.CO : HSBC cuts target price to DKK 231 from DKK 238 * Hermes HRMS.PA : Jefferies initiates coverage with buy rating; price target EUR 2,650 * Rathbone
3
A
A
A
B
B
B
B
B
C
C
C
C
D
F
G
G
H
I
K
L
M
P
P
R
S
S
S
T
V
W
Z
A
D
S
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.